Abstract
The complex diseases in the field of Neurology, Cardiology and Oncology have the most important impact on our society. The theoretical methods are fast and they involve some efficient tools aimed at discovering new active drugs specially designed for these diseases. The ontology of all the items that are linked with the molecule metabolism and the treatment of these diseases gives us the possibility to correlate information from different levels and to discover new relationships between complex diseases such as common drug targets and disease patterns. This review presents the ontologies used to process drug discovery and design in the most common complex diseases.
Keywords: Drug design, ontology, prostaglandin synthases, complex disease, Alzheimer, ’, s disease, Parkinson, multi-factorial diseases, Drug Discovery Investigations ontology (DDI), Protein Modification (PSI-MOD), Protein Ontology (PRO), National Drug Data File (NDDF), Drug Interaction Ontology (DIO), NCI Thesaurus (NCI-T), SNOMED-CT, RxNorm, NDF, EBI, (ICD-NA)
Current Pharmaceutical Design
Title: Ontologies of Drug Discovery and Design for Neurology, Cardiology and Oncology
Volume: 16 Issue: 24
Author(s): Jose M. Vazquez-Naya, Marcos Martinez-Romero, Ana B. Porto-Pazos, Francisco Novoa, Manuel Valladares-Ayerbes, Javier Pereira, Cristian R. Munteanu and Julian Dorado
Affiliation:
Keywords: Drug design, ontology, prostaglandin synthases, complex disease, Alzheimer, ’, s disease, Parkinson, multi-factorial diseases, Drug Discovery Investigations ontology (DDI), Protein Modification (PSI-MOD), Protein Ontology (PRO), National Drug Data File (NDDF), Drug Interaction Ontology (DIO), NCI Thesaurus (NCI-T), SNOMED-CT, RxNorm, NDF, EBI, (ICD-NA)
Abstract: The complex diseases in the field of Neurology, Cardiology and Oncology have the most important impact on our society. The theoretical methods are fast and they involve some efficient tools aimed at discovering new active drugs specially designed for these diseases. The ontology of all the items that are linked with the molecule metabolism and the treatment of these diseases gives us the possibility to correlate information from different levels and to discover new relationships between complex diseases such as common drug targets and disease patterns. This review presents the ontologies used to process drug discovery and design in the most common complex diseases.
Export Options
About this article
Cite this article as:
M. Vazquez-Naya Jose, Martinez-Romero Marcos, B. Porto-Pazos Ana, Novoa Francisco, Valladares-Ayerbes Manuel, Pereira Javier, R. Munteanu Cristian and Dorado Julian, Ontologies of Drug Discovery and Design for Neurology, Cardiology and Oncology, Current Pharmaceutical Design 2010; 16 (24) . https://dx.doi.org/10.2174/138161210792389199
DOI https://dx.doi.org/10.2174/138161210792389199 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacological Targeting of IDO-Mediated Tolerance for Treating Autoimmune Disease
Current Drug Metabolism Obesity: Current Treatment and Future Horizons
Mini-Reviews in Medicinal Chemistry Role of ARBs in the Blood Hypertension Therapy and Prevention of Cardiovascular Events
Current Drug Targets Iron Involvement in Multiple Signaling Pathways of Atherosclerosis: A Revisited Hypothesis
Current Medicinal Chemistry Vitamin D and Infectious Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of Catecholamines in Formation and Resolution of Pulmonary Oedema
Cardiovascular & Hematological Disorders-Drug Targets Statins May Prevent Atherosclerotic Disease in OSA Patients without Co-Morbidities?
Current Vascular Pharmacology Relations of Magnesium Intake with Metabolic Risk Factors and Risks of Type 2 Diabetes, Hypertension, and Cardiovascular Disease: A Critical Appraisal
Current Nutrition & Food Science Current Understanding of Dietary Polyphenols and their Role in Health and Disease
Current Nutrition & Food Science Roles of Adrenomedullin in Hypertension and Hypertensive Organ Damage
Current Hypertension Reviews Myocardial Ischemia-Reperfusion Injury, Antioxidant Enzyme Systems, and Selenium: A Review
Current Medicinal Chemistry Antihyperglycemic and Antidyslipidemic Activities of the <i>Aqueous Salvia hispanica</i> Extract in Diabetic Rat
Cardiovascular & Hematological Agents in Medicinal Chemistry Editorial (Thematic Issue: Novel Data on the Pathogenesis of Atherosclerosis, Treatment Targets, and New Therapeutic Interventions in Lipid-Related Cardiovascular Risk Factors)
Current Pharmaceutical Design Editorial (Heart Failure: The Need for Global Health Perspective)
Current Cardiology Reviews Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel Statement
Current Vascular Pharmacology Peripartum Cardiomyopathy: An Intensivist's Perspective
Current Women`s Health Reviews Fast Food Versus Slow Food and Hypertension Control
Current Hypertension Reviews Nutraceuticals and Dietary Supplements to Improve Quality of Life and Outcomes in Heart Failure Patients
Current Pharmaceutical Design Hypertension and Diabetes: Emphasis on the Renin – Angiotensin System and Insulin Resistance
Current Hypertension Reviews Use of Bromine-76 and Iodine-123 Radiohalogenated Tracers in the Drug Development Process
Current Pharmaceutical Design